About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Papillomavirus Research (Amsterdam, Netherlands)
›
Top Articles
Papillomavirus Research (Amsterdam, Netherlands)
4.6
(top 3%)
Impact Factor
5.1
(top 3%)
extended IF
27
(top 14%)
H-Index
225
authors
198
papers
3K
citations
743
citing journals
3K
citing authors
Most Cited Articles of Papillomavirus Research (Amsterdam, Netherlands)
Title
Year
Citations
European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
2015
128
Therapeutic vaccines for high-risk HPV-associated diseases
2018
97
The International Papillomavirus Society and its new journal, Papillomavirus Research
2015
78
Validation of the vaccine conspiracy beliefs scale
2016
75
No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study
2018
65
Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years
2017
60
Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines
2015
59
The feminization of HPV: How science, politics, economics and gender norms shaped U.S. HPV vaccine implementation
2017
55
Towards the global elimination of cervical cancer
2019
48
Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection
2015
47
Refining our understanding of cervical neoplasia and its cellular origins
2019
46
Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia
2015
45
Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action
2018
42
Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016
2017
40
Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis
2019
39
Knowledge, attitudes, and perception towards human papillomavirus among university students in Pakistan
2016
39
Seroconversion Following Anal and Genital HPV Infection in Men:
2015
38
Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study
2016
35
When and how often to screen for cervical cancer in three low- and middle-income countries: A cost-effectiveness analysis
2015
34
Molecular events leading to HPV-induced high grade neoplasia
2016
31
Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data
2016
31
Modulation of antigen presenting cell functions during chronic HPV infection
2017
28
HPV vaccination of immunocompromised hosts
2017
28
HPV and skin carcinogenesis
2019
27
Performance of the Xpert HPV assay in women attending for cervical screening
2015
26
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.